DK0957899T3 - Doseringsform til tilvejebringelse af stigende dosis lægemiddel - Google Patents

Doseringsform til tilvejebringelse af stigende dosis lægemiddel

Info

Publication number
DK0957899T3
DK0957899T3 DK97936421T DK97936421T DK0957899T3 DK 0957899 T3 DK0957899 T3 DK 0957899T3 DK 97936421 T DK97936421 T DK 97936421T DK 97936421 T DK97936421 T DK 97936421T DK 0957899 T3 DK0957899 T3 DK 0957899T3
Authority
DK
Denmark
Prior art keywords
dosage form
increasing dose
drug
provide increasing
administering
Prior art date
Application number
DK97936421T
Other languages
Danish (da)
English (en)
Inventor
Padmaja Shivanand
D Ayer Atul
D Wright Jeri
Andrew Lam
G Hamel Lawrence
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21814183&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0957899(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of DK0957899T3 publication Critical patent/DK0957899T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
DK97936421T 1996-08-16 1997-08-08 Doseringsform til tilvejebringelse af stigende dosis lægemiddel DK0957899T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2328696P 1996-08-16 1996-08-16
PCT/US1997/013816 WO1998006380A2 (en) 1996-08-16 1997-08-08 Dosage form for providing ascending dose of drug

Publications (1)

Publication Number Publication Date
DK0957899T3 true DK0957899T3 (da) 2003-04-22

Family

ID=21814183

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97936421T DK0957899T3 (da) 1996-08-16 1997-08-08 Doseringsform til tilvejebringelse af stigende dosis lægemiddel

Country Status (13)

Country Link
EP (1) EP0957899B1 (show.php)
JP (1) JP4393587B2 (show.php)
CN (2) CN101518517B (show.php)
AT (1) ATE234602T1 (show.php)
AU (1) AU3909597A (show.php)
CA (1) CA2263558A1 (show.php)
CY (1) CY2475B1 (show.php)
DE (1) DE69720055T2 (show.php)
DK (1) DK0957899T3 (show.php)
ES (1) ES2194210T3 (show.php)
PT (1) PT957899E (show.php)
WO (1) WO1998006380A2 (show.php)
ZA (1) ZA977254B (show.php)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US5837284A (en) 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
JP4714313B2 (ja) * 1996-09-30 2011-06-29 アルザ コーポレイション 剤形および薬剤の投与法
EP1690531A3 (en) * 1996-09-30 2010-01-20 Alza Corporation Dosage form and method for administering drug
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
DK0946151T3 (da) * 1996-11-25 2006-08-28 Alza Corp Doseringsform med stigende dosisfrigivelse
US6962997B1 (en) 1997-05-22 2005-11-08 Celgene Corporation Process and intermediates for resolving piperidyl acetamide steroisomers
AU2012232984B2 (en) * 1998-06-03 2015-10-29 Alza Corporation Methods and devices for providing prolonged drug therapy
KR100890537B1 (ko) * 1998-06-03 2009-03-27 알자 코포레이션 연장된 약물 치료를 제공하기 위한 방법 및 장치
AU2004200938B2 (en) * 1998-06-03 2006-09-14 Alza Corporation Methods and devices for providing prolonged drug therapy
JP2002516848A (ja) * 1998-06-03 2002-06-11 アルザ・コーポレーション 長時間の薬物療法を与える方法および装置
KR100827254B1 (ko) * 1998-06-03 2008-05-07 알자 코포레이션 연장된 약물 치료를 제공하기 위한 방법 및 장치
EP2020229A1 (en) 1998-11-02 2009-02-04 Elan Pharma International Limited Multiparticulate modified release composition
US6419960B1 (en) 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
US6673367B1 (en) * 1998-12-17 2004-01-06 Euro-Celtique, S.A. Controlled/modified release oral methylphenidate formulations
JP2002541093A (ja) 1999-04-06 2002-12-03 ファーマクエスト・リミテッド ｄ−ｔｈｒｅｏ−メチルフェニデートおよび第２のＣＮＳ刺激薬のパルス性送達のための薬学的投薬形態
CA2395974A1 (en) * 2000-01-20 2001-07-26 Suggy S. Chrai Multi-step drug dosage forms
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
CN1684670A (zh) * 2002-07-29 2005-10-19 阿尔扎公司 用于控制释放帕潘立酮的方法和剂型
AR041744A1 (es) * 2002-10-31 2005-05-26 Alza Corp Formas de dosificacion que proporcionan la liberacion ascendente de una formulacion liquida
US7988993B2 (en) 2002-12-09 2011-08-02 Andrx Pharmaceuticals, Inc. Oral controlled release dosage form
EP2184058B1 (en) 2003-09-26 2012-02-08 ALZA Corporation Drug coating providing high drug loading and methods for providing the same
MXPA06003452A (es) * 2003-09-26 2006-08-31 Johnson & Johnson Formulaciones de liberacion controlada que exhiben una velocidad de liberacion ascendente.
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
PL116330U1 (en) 2005-10-31 2007-04-02 Alza Corp Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
JP2011511782A (ja) 2008-02-12 2011-04-14 アボット・ラボラトリーズ 長期放出性ヒドロコドンアセトアミノフェンならびにその関連方法および用途
WO2015001488A1 (en) 2013-07-01 2015-01-08 Ranbaxy Laboratories Limited Extended-release tablets of paliperidone and processes of preparation thereof
CA2936746C (en) 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
MX2018007977A (es) * 2015-12-31 2018-11-09 Cadila Healthcare Ltd Forma farmaceutica osmotica de liberacion extendida que contiene una carga de clorhidrato de metilfenidato alta.
EP3501504A1 (en) 2017-12-22 2019-06-26 Pharmacia Polonica sp. z o.o. Modified release tablet of paliperidone and a process for the preparation thereof
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4842867A (en) * 1986-05-09 1989-06-27 Alza Corporation Pulsed drug delivery of doxylamine
GB2206046B (en) * 1987-06-25 1991-04-03 Alza Corp Multi-unit delivery system
US4874388A (en) * 1987-06-25 1989-10-17 Alza Corporation Multi-layer delivery system
US4915954A (en) * 1987-09-03 1990-04-10 Alza Corporation Dosage form for delivering a drug at two different rates
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
US5017381A (en) * 1990-05-02 1991-05-21 Alza Corporation Multi-unit pulsatile delivery system
ES2149250T3 (es) * 1993-04-23 2000-11-01 Novartis Ag Dispositivo para la administracion de medicamentos con liberacion controlada.
GB9402203D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Pharmaceutical formulation

Also Published As

Publication number Publication date
EP0957899B1 (en) 2003-03-19
ES2194210T3 (es) 2003-11-16
CN101518517A (zh) 2009-09-02
HK1021886A1 (zh) 2000-07-14
WO1998006380A2 (en) 1998-02-19
DE69720055D1 (de) 2003-04-24
ZA977254B (en) 1998-05-11
CN100484518C (zh) 2009-05-06
CN101518517B (zh) 2014-11-26
EP0957899A2 (en) 1999-11-24
CA2263558A1 (en) 1998-02-19
AU3909597A (en) 1998-03-06
CN1228691A (zh) 1999-09-15
CY2475B1 (en) 2005-06-03
PT957899E (pt) 2003-07-31
DE69720055T2 (de) 2003-09-11
JP2000516610A (ja) 2000-12-12
ATE234602T1 (de) 2003-04-15
HK1137355A1 (zh) 2010-07-30
JP4393587B2 (ja) 2010-01-06
WO1998006380A3 (en) 1998-05-14

Similar Documents

Publication Publication Date Title
DK0957899T3 (da) Doseringsform til tilvejebringelse af stigende dosis lægemiddel
DK0932388T3 (da) Doseringsform og fremgangsmåde til indgivelse af lægemidler
ATE325606T1 (de) Dosisform mit ansteigender dosisfreisetzung
DK1035834T3 (da) Osmotisk doseringsform omfattende en første og anden coating
NO924209L (no) Doseringsform for tilfoersel av et antiparkinsonmiddel
DK0869808T3 (da) Anvendelse af Glu-Trp-dipeptider til fremstilling af et lægemiddel til behandling af forskellige tilstande, der involverer neovaskularisation
DK0600033T3 (da) Doseringsform til afgivelse af lægemiddel i et kort tidsrum
ATE306266T1 (de) Verbesserte verabreichungstechnik für multiple medikamentengaben
NO306377B1 (no) Doseform for avgivelse av et medikament
DK0490991T3 (da) Doseringsform til oral administration af hypoglykæmisk glipizid
DK0642788T3 (da) Tramadolsaltholdigt lægemiddel med forsinket frigivelse af aktivt stof
DE122011100032I1 (de) Verwendung von n-substituierten pyridonen als tumornekrose-faktor alpha hemmer.
WO1994027589A3 (en) Antidepressant dosage form
NO20101190L (no) Anvendelse av buprenorfin i fremstillingen av et medikament
BR9802537A (pt) Método para anestesiar um paciente humano antes de cirurgias de porte dose unitária e sistema farmacêutico para administração
ATE292453T1 (de) Antivirale arznei
ATE284206T1 (de) Transdermal verabreichtes dextromethorphan als hustenmittel
ATE268174T1 (de) Sibutramin und orlistat enthaltende pharmazeutische zusammensetzungen
FI930097A7 (fi) Annostusmuoto lääkeaineen antamiseksi vuorokausiterapian toteuttamista varten
DK1096923T3 (da) Blister indeholdende et transdermalt terapeutisk system og en enkeltdosisindgivelsesform
IT1145989B (it) Composto farmaceutico contenente 1.2.3.carbossipropionil ossietile 2 metile 5 nitroimidazolo quale a gente terapeutico attivo contro le malattie causate da germi anaerobi
DK117291D0 (da) Doseringsform til oral indgift af laegemiddelstoffer